TITLE

Steatosis affects chronic hepatitis C progression in a genotype specific way

AUTHOR(S)
Rubbia-Brandt, L.; Fabris, P.; Poganin, S.; Leandro, G.; Male, P-J.; Giostra, E.; Carlotto, A.; Bozzola, L.; Smedile, A.; Negro, F.
PUB. DATE
March 2004
SOURCE
Gut;Mar2004, Vol. 53 Issue 3, p406
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Liver steatosis is frequent in chronic hepatitis C, particularly in patients infected with hepatitis C virus (HCV) genotype 3. The aim of this study was to determine the relationship between steatosis and fibrosis in chronic hepatitis C as a function of viral genotype. Methods: A multivariable logistic regression analysis was carried out in 755 chronic hepatitis C patients (mean body mass index (BMI) 24.11 kg/m² 178 with genotype 3), consecutively admitted to three referral hospitals. Liver histology showed steatosis in 315 and fibrosis in 605 patients, of whom 187 had cirrhosis (78 compensated and 109 decompensated). Results: Steatosis was independently associated with fibrosis (p<0.001), genotype 3 (p<0.001), BMI (p<0.001), ongoing alcohol abuse (p<0.001), and age (p=0.001). Fibrosis was associated with the Metavir activity score (p<0.001), age (p<0.001), steatosis (p=0.001), past alcohol abuse for >5 years (p=0.015), and BMI (p=0.034). When regression analysis was repeated on patients divided according to viral genotype (that is, 3 v non-3) to identify type specific risk factors, steatosis was associated with ongoing alcohol abuse (p<0.001) and age (p=0.01) only in non-3 genotype infected patients and with Metavir activity (p = 0.044) only in genotype 3 infected patients. Similarly, fibrosis was associated with steatosis only in genotype 3 infected individuals (p=0.018), and with past alcohol abuse (p=0.003) and (marginally) diabetes (p = 0.078) only in non-3 genotype infected patients. Conclusions: Steatosis influences chronic hepatitis C progression in a genotype specific way. Patients infected with genotype 3 and histologically confirmed steatosis should not be deferred from effective antiviral therapy.
ACCESSION #
13492621

 

Related Articles

  • Viral Sequence Variation in Chronic Carriers of Hepatitis C Virus Has a Low Impact on Liver Steatosis. Depla, Marion; D'Alteroche, Louis; Le Gouge, Amélie; Moreau, Alain; Hourioux, Christophe; Meunier, Jean-Christophe; Gaillard, Julien; De Muret, Anne; Bacq, Yannick; Kazemi, Farhad; Avargues, Aurélie; Roch, Emmanuelle; Piver, Eric; Gaudy-Graffin, Catherine; Giraudeau, Brunoq; Roingeard, Philippe // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Most clinical studies suggest that the prevalence and severity of liver steatosis are higher in patients infected with hepatitis C virus (HCV) genotype 3 than in patients infected with other genotypes. This may reflect the diversity and specific intrinsic properties of genotype 3 virus proteins....

  • Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP). Mirandola, Silvia; Bowman, David; Hussain, Mahmood M; Alberti, Alfredo // Nutrition & Metabolism;2010, Vol. 7, p13 

    Liver steatosis is a frequent histological feature in patients chronically infected with hepatitis C virus (HCV). The relationship between HCV and hepatic steatosis seems to be the result of both epigenetic and genetic factors. In vivo and in vitro studies have shown that HCV can alter...

  • Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Castéra, L.; Hézode, C.; Roudot-Thoraval, F.; Lonjon, I.; Zafrani, E-S.; Pawlotsky, J-M.; Dhumeaux, D. // Gut;Mar2004, Vol. 53 Issue 3, p420 

    Background and aim: Recent studies suggest that liver steatosis in chronic hepatitis C may be the expression of a direct cytopathic effect of hepatitis C virus (HCV), particularly in patients infected with genotype 3. To investigate this hypothesis, we studied the relationship between steatosis...

  • Hepatitis C in Childhood. Arora, N. K.; Das, M. K.; Mathur, P.; Mishra, R. // International Seminars in Pediatric Gastroenterology & Nutrition;Dec2004, Vol. 12 Issue 4, p3 

    Presents clinical information concerning hepatitis C virus (HCV) infection in children. Genotypes of HCV that have been isolated; Epidemiology of HCV; Therapeutic options for HCV infections.

  • Host genetic determinants in hepatitis C virus infection. Yee, L.J. // Genes & Immunity;Jun2004, Vol. 5 Issue 4, p237 

    In addition to viral and environmental/behavioural factors, host genetic diversity is believed to contribute to the spectrum of clinical outcomes in hepatitis C virus (HCV) infection. This paper reviews the literature with respect to studies of host genetic determinants of HCV outcome and...

  • The CCR5-Δ32 mutation: impact on disease outcome in individuals with hepatitis C infection From a single source. Goulding, C.; Murphy, A.; MacDonald, G.; Barrett, S.; Crowe, J.; Hegarty, J.; McKiernan, S.; Kelleher, D. // Gut;Aug2005, Vol. 54 Issue 8, p1157 

    Background and aims: Chemokines are small polypeptides, a major function of which is lymphocyte recruitment and trafficking. The aim of this study was to assess the involvement of inherited variations in CCR2, CCR5, and the ligand RANTES in determining disease outcome in hepatitis C virus (HCV)...

  • Study of hepatitis C virus infection in 213 Hungarian patients with Sjögren's syndrome. Szodoray, Péter; Csepregi, Antal; Héjjas, Mária; Horányi, Margit; Zeher, Margit // Rheumatology International;Sep2001, Vol. 21 Issue 1, p6 

    In the current study we investigated 213 randomly selected Hungarian patients diagnosed with primary Sjögren's syndrome (SS). All patients were monitored for hepatitis C virus (HCV) infection and 13 were positive. We compared HCV-negative and -positive patients and made observations on how...

  • Association of Transforming Growth Factor -- β1 Functional Polymorphisms with Natural Clearance of Hepatitis C Virus. Kimura, Tomomi; Saito, Takafumi; Yoshimura, Mika; Song Yixuan; Baba, Masanori; Guijin Ji; Muramatsu, Masaaki; Kawata, Sumio // Journal of Infectious Diseases;5/15/2006, Vol. 193 Issue 10, p1371 

    Transforming growth factor (TGF)-β1 suppresses the proliferation and cytotoxicity of natural killer (NK) cells, which play critical roles in resolving hepatitis C virus (HCV) infection, especially during the acute phase. We examined 230 anti-HCV antibody-positive subjects for HCV RNA and the...

  • Effect of Heptitis C Virus Core Protein on Cellular Gene Expression: Specific Inhibition of Cyclooxygenase 2. Jhaveri, Ravi; Kundu, Pallob; Shapiro, Alan M.; Venkatesan, Arun; Dasgupta, Asim // Journal of Infectious Diseases;5/1/2005, Vol. 191 Issue 9, p1498 

    Hepatitis C virus (HCV) core protein plays a significant role in the alteration of cellular gene expression. We expressed HCV core protein using a tetracycline-inducible expression system in HeLa cell lines. Profiles of gene expression in cells expressing the HCV core protein were compared with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics